Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.

Damage to axons is taken as a key factor of disability in multiple sclerosis, but its pathogenesis is largely unknown. Axonal injury is believed to occur as a consequence of demyelination and was recently shown to be a feature even of the early disease stages. The present study was aimed at characterizing the association of axonal injury and histopathological hallmarks of multiple sclerosis such as demyelination, cellular infiltration and expression of inflammatory mediators. Therefore, axon reduction and signs of acute axonal damage were quantified in early lesion development of chronic multiple sclerosis and correlated with demyelinating activity and inflammation. Patients with secondary progressive multiple sclerosis revealed the most pronounced axonal injury, whereas primary progressive multiple sclerosis patients surprisingly showed relatively little acute axonal injury. Acute axonal damage, as defined by the accumulation of amyloid precursor protein (APP), was found to occur not only in active demyelinating but also in remyelinating and inactive demyelinated lesions with a large inter-individual variability. Only few remyelinating lesions were adjacent to areas of active demyelination. In this minority of lesions, axonal damage may have originated from the neighbourhood. APP expression in damaged axons correlated with the number of macrophages and CD8-positive T lymphocytes within the lesions, but not with the expression of tumour necrosis factor-alpha (TNF-alpha) or inducible nitric oxide synthase (iNOS). Axonal injury is therefore, at least in part, independent of demyelinating activity, and its pathogenesis may be different from demyelination. This has major implications for therapeutic strategies, which aim at preventing both demyelination and axonal loss.

[1]  C. Lucchinetti,et al.  The controversy surrounding the pathogenesis of the multiple sclerosis lesion. , 1997, Mayo Clinic proceedings.

[2]  P M Matthews,et al.  Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. , 1996, Brain : a journal of neurology.

[3]  W. Mcdonald,et al.  The longstanding MS lesion. A quantitative MRI and electron microscopic study. , 1991, Brain : a journal of neurology.

[4]  P M Matthews,et al.  Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. , 1998, Brain : a journal of neurology.

[5]  K. Selmaj,et al.  Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro , 1988, Annals of neurology.

[6]  D. Graham,et al.  Amyloid precursor protein accumulates in white matter at the margin of a focal ischaemic lesion , 1997, Brain Research.

[7]  W. Brück,et al.  Identification of macrophage populations expressing tumor necrosis factor-α mRNA in acute multiple sclerosis , 1998, Acta Neuropathologica.

[8]  H. Lassmann,et al.  Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination , 1998, Annals of neurology.

[9]  J. Logel,et al.  Synthesis of cRNA probes from PCR-generated DNA. , 1992, BioTechniques.

[10]  V. Perry,et al.  Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.

[11]  F. Barkhof,et al.  Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis , 1996, Neurology.

[12]  T. Kitamoto,et al.  Alzheimer's amyloid precursor protein accumulates within axonal swellings in human brain lesions , 1992, Neuroscience Letters.

[13]  Ian G. Charles,et al.  Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[14]  W. Brück,et al.  Macrophages in multiple sclerosis. , 1996, Immunobiology.

[15]  H. Lassmann,et al.  Immunopathology of multiple sclerosis: Report on an international meeting held at the Institute of Neurology of the University of Vienna , 1998, Journal of Neuroimmunology.

[16]  G. Barker,et al.  Spinal cord atrophy and disability in MS , 1998, Neurology.

[17]  Dr. med. Hans Lassmann Comparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis , 1983, Schriftenreihe Neurologie / Neurology Series.

[18]  P M Matthews,et al.  Axonal dysfunction and disability in a relapse of multiple sclerosis: Longitudinal study of a patient , 1997, Neurology.

[19]  G. Barker,et al.  1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis , 1997, Journal of neurology, neurosurgery, and psychiatry.

[20]  G. Giovannoni Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis , 1998, Multiple sclerosis.

[21]  Hans Lassmann,et al.  Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology , 1997, Annals of neurology.

[22]  F. Barkhof,et al.  Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.

[23]  A. Thompson,et al.  Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. , 1995, Brain : a journal of neurology.

[24]  M. Charles McAlpine's Multiple Sclerosis, 2nd Ed. , 1991 .

[25]  G. L. Li,et al.  Changes of beta-amyloid precursor protein after compression trauma to the spinal cord: an experimental study in the rat using immunohistochemistry. , 1995, Journal of neurotrauma.

[26]  O. Khan,et al.  Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases , 1997, Multiple sclerosis.

[27]  Moses Rodriguez,et al.  Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis , 1998, Nature Medicine.

[28]  E. J. Green,et al.  Temporal and Regional Patterns of Axonal Damage following Traumatic Brain Injury: A Beta‐amyloid Precursor Protein Immunocytochemical Study in Rats , 1997, Journal of neuropathology and experimental neurology.

[29]  S. Hauser,et al.  Identification of autoantibodies associated with myelin damage in multiple sclerosis , 1999, Nature Medicine.

[30]  R. S. Sloviter,et al.  Apoptosis and necrosis induced in different hippocampal neuron populations by repetitive perforant path stimulation in the rat , 1996, The Journal of comparative neurology.

[31]  D. Goeddel,et al.  Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. , 1985, Nucleic acids research.

[32]  B. Trapp,et al.  Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions , 1994, Journal of Neuroimmunology.

[33]  W. Brück,et al.  Central nervous system TNFα-mRNA expression during rabbit experimental pneumococcal meningitis , 1997, Neuroscience Letters.

[34]  I. Charles,et al.  Molecular cloning and structural organization of the human inducible nitric oxide synthase gene (NOS2). , 1996, Biochemical and biophysical research communications.

[35]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[36]  Moses Rodriguez,et al.  Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis , 1996, Brain pathology.

[37]  R. Hohlfeld,et al.  Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. , 1997, Brain : a journal of neurology.

[38]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[39]  Hans Lassmann,et al.  Monocyte/macrophage differentiation in early multiple sclerosis lesions , 1995, Annals of neurology.

[40]  L. Ignarro,et al.  Nitric oxide as a potential pathological mechanism in demyelination: Its differential effects on primary glial cellsin vitro , 1994, Neuroscience.

[41]  J. Trojanowski,et al.  Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and beta-amyloid peptide after experimental brain injury in the rat , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[42]  A. Thompson,et al.  Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. , 1996, Brain : a journal of neurology.